These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2016725)

  • 1. New derivatives of kanamycin B obtained by modifications and substitutions in position 6''. 2. In vitro and computer-aided toxicological evaluation with respect to interactions with phosphatidylinositol.
    Mingeot-Leclercq MP; Van Schepdael A; Brasseur R; Busson R; Vanderhaeghe HJ; Claes PJ; Tulkens PM
    J Med Chem; 1991 Apr; 34(4):1476-82. PubMed ID: 2016725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
    Van Schepdael A; Delcourt J; Mulier M; Busson R; Verbist L; Vanderhaeghe HJ; Mingeot-Leclercq MP; Tulkens PM; Claes PJ
    J Med Chem; 1991 Apr; 34(4):1468-75. PubMed ID: 2016724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
    Van Schepdael A; Busson R; Vanderhaeghe HJ; Claes PJ; Verbist L; Mingeot-Leclercq MP; Brasseur R; Tulkens PM
    J Med Chem; 1991 Apr; 34(4):1483-92. PubMed ID: 2016726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimicrobial and toxicological studies of amino acid and peptide derivatives of kanamycin A and netilmicin.
    Kotretsou S; Mingeot-Leclercq MP; Constantinou-Kokotou V; Brasseur R; Georgiadis MP; Tulkens PM
    J Med Chem; 1995 Nov; 38(23):4710-9. PubMed ID: 7473599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition induced by aminoglycoside antibiotics--II. Conformational analysis.
    Mingeot-Leclercq MP; Piret J; Tulkens PM; Brasseur R
    Biochem Pharmacol; 1990 Aug; 40(3):499-506. PubMed ID: 2383283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of streptomycin and streptomycylamine derivatives with negatively charged lipid layers. Correlation between binding, conformation of complexes and inhibition of lysosomal phospholipase activities.
    Brasseur R; Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM; Ruysschaert JM
    Biochem Pharmacol; 1985 Apr; 34(7):1035-47. PubMed ID: 3985990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics--I. Biochemical analysis.
    Mingeot-Leclercq MP; Piret J; Brasseur R; Tulkens PM
    Biochem Pharmacol; 1990 Aug; 40(3):489-97. PubMed ID: 2383282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies.
    Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM
    Antimicrob Agents Chemother; 1983 Mar; 23(3):440-9. PubMed ID: 6847172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of substrate organization on the activity and on the mechanism of gentamicin-induced inhibition of rat liver lysosomal phospholipase A1.
    Piret J; Kishore BK; Tulkens PM
    Biochem Pharmacol; 1992 Feb; 43(4):895-8. PubMed ID: 1540243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
    Montenez JP; Van Bambeke F; Piret J; Brasseur R; Tulkens PM; Mingeot-Leclercq MP
    Toxicol Appl Pharmacol; 1999 Apr; 156(2):129-40. PubMed ID: 10198278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular parameters involved in aminoglycoside nephrotoxicity.
    Mingeot-Leclercq MP; Brasseur R; Schanck A
    J Toxicol Environ Health; 1995 Mar; 44(3):263-300. PubMed ID: 7897692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
    Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
    Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study.
    Carlier MB; Laurent G; Tulkens P
    Arch Toxicol Suppl; 1984; 7():282-5. PubMed ID: 6595993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of kidney lysosomal phospholipase A1 by aminoglycosides is a novel variant of substrate depletion inhibition.
    Hostetler KY; Jellison EJ
    J Pharmacol Exp Ther; 1990 Jul; 254(1):188-91. PubMed ID: 2366181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessibility of aminoglycosides, isolated and in interaction with phosphatidylinositol, to water. A conformational analysis using the concept of molecular hydrophobicity potential.
    Mingeot-Leclercq MP; Tulkens PM; Brasseur R
    Biochem Pharmacol; 1992 Nov; 44(10):1967-75. PubMed ID: 1449515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers.
    Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM
    Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and antibacterial activities of conformationally constrained kanamycin A derivatives.
    Zhang W; Chen Y; Liang Q; Li H; Jin H; Zhang L; Meng X; Li Z
    J Org Chem; 2013 Jan; 78(2):400-9. PubMed ID: 23228010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regioselective glycosylation of neamine core: a facile entry to kanamycin B related analogues.
    Chou CH; Wu CS; Chen CH; Lu LD; Kulkarni SS; Wong CH; Hung SC
    Org Lett; 2004 Feb; 6(4):585-8. PubMed ID: 14961629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 5-deoxy-5-fluoro and 5-deoxy-5,5-difluoro derivatives of kanamycin B and its analogs. Study on structure-toxicity relationships.
    Shitara T; Kobayashi Y; Tsuchiya T; Umezawa S
    Carbohydr Res; 1992 Aug; 232(2):273-90. PubMed ID: 1423360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.